Investec Bank Plc has submitted a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc on August 14, 2026.
The disclosure was filed under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the offer, establishing its connected status under the Code.
The filing confirms that Investec conducted dealings in ordinary shares of Advanced Medical Solutions Group Plc on August 14, 2026, covering both purchases and sales.
On the purchase side, Investec acquired a total of 248,854 ordinary shares, with prices ranging from a low of 280.75 pence to a high of 281.5 pence per unit.
On the sales side, a total of 203,984 ordinary shares were sold, with prices ranging between 281 pence and 281.5 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or option dealings were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could constitute an inducement to deal or refrain from dealing in relation to the offer.
The bank also confirmed no agreements or understandings exist relating to voting rights under any option or to the future acquisition or disposal of securities linked to any derivative.
The disclosure was made public on August 17, 2026, with contact details provided for Priyali Bhattacharjee as the named contact for the filing.
Such disclosures are required to be submitted to a Regulatory Information Service under the rules of the Takeover Panel, which oversees compliance with the Takeover Code in the United Kingdom.
The Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code for any parties involved in offer-related transactions.
